CGT Global Products

Mobilized Leukopaks

CGT Global Mobilized Leukopaks are collected from healthy IRB consented donors that are injected with Granulocyte-Colony Stimulating Factor (G-CSF), Plerixafor, or a combination of Plerixafor and G-CSF, which increases circulating leukocytes and stimulates the bone marrow to produce a large number of hematopoietic and progenitor stem cells and mobilizes these cells into the bloodstream, allowing for enriched CD34+ hematopoietic stem cells from a single donor as compared to traditional Leukopaks. Collecting CD34+ stem cells from a single donor eliminates donor-to-donor variation, allows scalability of stem cell studies, and decreases same cell variability.

CGT Global Mobilized Leukopaks are collected in CLIA Certified clinics registered by the FDA.

CGT Global Leukopak Bag

Fresh Mobilized Leukopaks | G-CSF + PLX

Select options This product has multiple variants. The options may be chosen on the product page
Mobilized leukopak collected with Plerixafor, enriched with CD34+ stem cells for advanced cell therapy research

Fresh Mobilized Leukopaks | Plerixafor

Select options This product has multiple variants. The options may be chosen on the product page
Mobilized leukopak collected with G-CSF, enriched with CD34+ hematopoietic stem cells for immunotherapy research” “G-CSF-mobilized leukopak product containing stem and progenitor cells for CAR-T and gene therapy development

Fresh Mobilized Leukopaks | G-CSF

Select options This product has multiple variants. The options may be chosen on the product page
“Mobilized leukopak collected with G-CSF and Plerixafor, providing high CD34+ stem cell yield for clinical research”

Fresh Mobilized Leukopaks | G-CSF + Plerixafor

Select options This product has multiple variants. The options may be chosen on the product page